TradeUP Acquisition Corp.
UPTD
NASDAQ Capital Market9.34
USD
-0.62
- -
CIK
0001844417
ISIN
US89268A1079
CUSIP
89268A107
Return %
Stock
S&P500
1Y
-7.52
26.53
3Y
-4.21
76.60
5Y
-4.21
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jianwei Li
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 437 Madison Avenue New York City NY United States of America 10022
- IPO Date
- Sep 14, 2021
- CIK
- 0001844417
- Similar Companies
- Business
- TradeUP Acquisition Corp. functioned as a specialized acquisition entity, initially lacking substantial operational activities. The firm was established with the intent to execute a merger, equity exchange, asset acquisition, share purchase, restructuring, or another form of business combination with one or more companies. It directed its search primarily towards opportunities within the technology sector. Founded in 2021 and based in New York, New York, the company successfully completed its strategic merger with Estrella Biopharma, Inc. in late 2023. Consequently, the integrated enterprise now operates as Estrella Immunopharma, Inc., a biopharmaceutical company concentrating on the advancement of T-cell therapies for cancer, with its shares trading on NASDAQ under new symbols.
Estrella Immunopharma Nears Completion Of SPAC Listing
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination